代谢与慢性肾脏病的交叉路口
本研究采用非靶向代谢组学方法,在MDRD队列及AASK验证队列中探索CKD预后生物标志物。发现核糖酸、富马酸和尿囊素三种血清代谢物与CKD患者死亡风险显著相关,且经肾小球滤过率和尿蛋白等多变量校正后仍独立相关。
要点
- 核糖酸、富马酸和尿囊素与CKD患者死亡风险显著相关。
- 上述关联经eGFR和尿蛋白等多变量校正后仍存在。
- 代谢组学为CKD预后评估提供了新方向。
核心结论
- 三种血清代谢物(核糖酸、富马酸、尿囊素)与CKD患者死亡风险显著相关,且独立于eGFR和尿蛋白等临床协变量。
研究设计与样本
- 研究采用非靶向代谢组学方法,在MDRD队列中探索,并在AASK队列中进行验证。
主要发现
- 核糖酸、富马酸和尿囊素三种血清代谢物与CKD患者死亡风险显著相关。
- 经包括肾小球滤过率和尿蛋白在内的多变量统计校正后,关联仍显著。
临床怎么用
- 代谢组学标志物有望用于CKD的诊断和预后预测,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sensitive and useful biomarkers for predicting chronic kidney disease (CKD) and its prognosis are urgently needed. Using a nontargeted metabolomic approach, Hu et al. explored an established CKD cohort, Modification of Diet in Renal Disease, as well as a validation cohort, African American Study of Kidney Disease and Hypertension. They identified 3 serum metabolites (ribonate, fumarate, and allantoin) significantly associated with mortality in CKD even after statistical adjustment by multiple clinical covariates including glomerular filtration rate and urinary protein. Their finding develops a new aspect for diagnosing and predicting the prognosis of CKD.
引用
- Suzuki T, Abe T. Crossroads of metabolism and CKD. Kidney Int. 2018. PMID: 30031444. doi:10.1016/j.kint.2018.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。